中遠海運國際(00517.HK)委任朱昌宇為執行董事、董事會主席兼董事總經理
格隆匯4月17日丨中遠海運國際(00517.HK)宣佈,自2023年4月17日起,朱建輝因退休辭任公司執行董事、董事會主席兼董事總經理職務。因此,朱建輝不再擔任公司按香港聯合交易所有限公司證券上市規則第3.05條項下指定授權代表("授權代表")、公司企業管治委員會、戰略發展委員會及風險管理委員會主席、以及薪酬委員會及提名委員會成員。
同日,朱昌宇獲委任為公司執行董事、董事會主席兼董事總經理,授權代表及公司企業管治委員會、戰略發展委員會及風險管理委員會主席,以及薪酬委員會及提名委員會成員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.